Esperion was founded in 2008. Since then, our teams have worked diligently to discover, develop and commercialize medicines that help people reduce their LDL-cholesterol. Today and every day, we strive to reimagine how those in need manage their heart health. In pursuit of this effort, we’re committed to setting – and reaching – goals that support our patients, our healthcare providers and society at large.
We have set a goal to give prescribers innovative options to reduce LDL-cholesterol, with the goal of reducing overall cardiovascular risk.
We have set a goal to empower patients to manage their LDL-cholesterol and educate them on the importance of cardiovascular risk reduction.
We have set a goal to provide at-risk populations with access to available treatments.
Esperion, Reaching Goals
We are growing our pipeline with an ongoing cardiovascular outcomes trial (CVOT) and an investigational early-stage oral PCSK9 inhibitor program.
Our Vision
Innovation Today, for Healthier Lives Tomorrow
Our Mission
At Esperion, we are working tirelessly to deliver innovative medicines that help patients reach their goals today, tomorrow, and into the future.
Our Core Values
Collaboration
We promote an inclusive and supportive environment that, regardless of title or rank, fosters open discussion and debate.
Courage
We challenge the status quo with entrepreneurial spirit as we remain steadfastly committed to problem-solving with agility, resilience, and creativity.
People
We value each other, and we invest in building strong relationships and creating opportunities for personal and professional growth.
Passion
We are committed to making a difference for patients living with hypercholesterolemia and will confront every challenge with optimism and resourcefulness.
Accountability
We hold ourselves and each other to the highest level of personal and professional integrity, by owning what we say and delivering on our commitments.
